Results 111 to 120 of about 107,836 (304)

Disrupting Helicobacter pylori Iron Homeostasis With Bismuth Nanodrug‐Mediated Nutritional Trap for Targeted Gastric Infection Therapy

open access: yesAdvanced Science, EarlyView.
A “nutritional trap” strategy centered on disrupting bacterial iron homeostasis is proposed. The synthesized Bi‐TP@FU (TBF) can target Helicobacter pylori, interfere with the bacterial iron uptake and utilization processes to disrupt its iron homeostasis, induce bacterial death, and meanwhile preserve the balance of the intestinal flora.
Tianye Fang   +13 more
wiley   +1 more source

Oral glucose tolerance test for standard diet group during treatment phase. [PDF]

open access: yes
Oral glucose tolerance test for standard diet group during treatment phase.
Peter W. Mwangi (18071426)   +3 more
core   +1 more source

Oral Delivery Systems for Food‐Derived Bioactive Peptides: Enhancing Stability, Bioavailability, and Health Benefits

open access: yesAdvanced Science, EarlyView.
Advanced delivery systems—including nanoparticles, nanoemulsions, liposomes, and hydrogels—protect food‐derived bioactive peptides from gastrointestinal degradation and bitterness. These systems enable pH‐responsive release, enhance intestinal absorption, and improve therapeutic efficacy against oxidative stress, metabolic disorders, cancer, and ...
Yu Xu   +5 more
wiley   +1 more source

Oral glucose tolerance test for LPHC diet group during treatment phase. [PDF]

open access: yes
Oral glucose tolerance test for LPHC diet group during treatment phase.
Peter W. Mwangi (18071426)   +3 more
core   +1 more source

Programmable Nanobody‐Targeting Chimeras Enable Intracellular Viral Protein Degradation

open access: yesAdvanced Science, EarlyView.
Nab‐TAC enables targeted degradation of HBV surface antigen (HBsAg) in vivo. By fusing nanobody‐based recognition domains with programmable proteasome‐recruiting degradation signals, Nab‐TAC reduces HBsAg levels in a hydrodynamic HBV mouse model. ABSTRACT Chronic hepatitis B virus (HBV) infection remains a major global health challenge, largely because
Max Yu‐Chen Pan   +11 more
wiley   +1 more source

Area under the curve for LPHC during the oral glucose tolerance test during treatment phase. [PDF]

open access: yes
Area under the curve for LPHC during the oral glucose tolerance test during treatment phase.
Peter W. Mwangi (18071426)   +3 more
core   +1 more source

UNIVERSAL VS SELECTIVE SCREENING OF GESTATIONAL DIABETES MELLITUS BY ORAL GLUCOSE TOLERANCE TEST AT 24-28 WEEKS PREGNANCY

open access: yesPakistan Armed Forces Medical Journal, 2019
Objective: To compare universal screening of pregnant ladies for Gestational Diabetes Mellitus (GDM) with selective high risk screening by one step Oral Glucose Tolerance Test (OGTT) at 24-28 weeks pregnancy. Study Design: Comparative cross-sectional
Humaira Tariq   +4 more
doaj   +2 more sources

Identifying a Csmd3+ Microglial Subpopulation that Drives Cold‐to‐Hot Transition and Immune‐Cure in Glioblastoma

open access: yesAdvanced Science, EarlyView.
The study establishes an immune‐cure (ICu) mouse model based on a TMEMed G422TN‐GBM system that faithfully recapitulates human TMEMed GBM. scRNA‐seq analysis reveals a Csmd3+ microglial subset with innate immune memory (IIM) potential that potently suppresses GBM growth, drives a TME cold‐to‐hot transition, and induces 100% ICu in long‐term survival ...
Hai‐Feng Jiang   +12 more
wiley   +1 more source

Oral Glucose Tolerance Test among Adolescents with Impaired Fasting Blood Glucose [PDF]

open access: yes, 2016
Background: Type 2 Diabetes Mellitus (DM) is emerging as a major health problem even amongst children and adolescents. The onset is usually preceded by period of impaired glucose metabolism known as Impaired Fasting Glucose (IFG) and or Impaired Glucose ...
Jaja, Tamunopriye, Okoh, Boma
core   +1 more source

Area under the standard diet during the oral glucose tolerance test during treatment phase. [PDF]

open access: yes
Area under the standard diet during the oral glucose tolerance test during treatment phase.
Peter W. Mwangi (18071426)   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy